Ceterix Orthopaedics Competitors and Similar CompaniesClear all

Ceterix Orthopaedics's competitors and similar companies include Seegene, OrthoPediatrics and Genotypic Technology.

	Ceterix Orthopaedics Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.	Seegene Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.	OrthoPediatrics OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.	Genotypic Technology Genotypic Technology is a company that provides genomics, microarray, bioinformatics and next-generation sequencing (NGS) solutions and services.
Founding Date	Founding Date 2010	Founding Date 2000	Founding Date 2006	Founding Date 1998
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices	Tags Healthcare biotech healthtech medical devices
Locations	Locations Fremont, US HQ	Locations Seoul, KR HQ Contagem, BR Toronto, CA Düsseldorf, DE Genova, IT Ciudad De México, MX Dubai, AE see more	Locations Warsaw, US HQ	Locations Bengaluru, IN HQ
Employees	Employees 2031% decrease	Employees 88478% increase	Employees 9418% increase	Employees 1113% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₩367.4b (FY, 2023)	Revenue (est.) $148.7m (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₩120.9b (FY, 2023)	Cost of goods $37.5m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₩249.6b (FY, 2023)	Gross profit $111.3m (FY, 2023)	Gross profit N/A
Net income	Net income N/A	Net income ₩733.2m (FY, 2023)	Net income ($21m) (FY, 2023)	Net income N/A
Operating ⚠
Countries	Countries N/A	Countries 48 (Q2, 2020)	Countries 36 (Nov, 2017)	Countries N/A
Distributors	Distributors N/A	Distributors 100 (Q3, 2022)	Distributors 31 (Nov, 2017)	Distributors N/A
Funding
Total funding raised	Total funding raised $ 53m	Total funding raised N/A	Total funding raised $ 39m	Total funding raised N/A